Hypertonic saline and pentoxifylline attenuates gut injury after hemorrhagic shock: The kinder, gentler resuscitation

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 4, 2007, Pages 818-827

  Deree, Jessica ^a   De Campos, Tercio ^a   Shenvi, Edna ^a   Loomis, William H ^a   Hoyt, David B ^a   Coimbra, Raul ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE   (United States)

Author keywords

Hemorrhagic shock; Hypertonic saline; NF B; Nitric oxide; Pentoxifylline

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; HEME OXYGENASE 1; HYDROXYAMPHETAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HEMORRHAGIC SHOCK; ILEUM; IMMUNOMODULATION; INTESTINE INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RESUSCITATION; WESTERN BLOTTING;

ABDOMINAL INJURIES; ANIMALS; CYTOKINES; DOWN-REGULATION; DRUG COMBINATIONS; FLUID THERAPY; HEME OXYGENASE-1; ILEUM; INFLAMMATION; ISOTONIC SOLUTIONS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SALINE SOLUTION, HYPERTONIC; SHOCK, HEMORRHAGIC;

EID: 34247237289     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31802d9745     Document Type: Article

References (59)

1. Vincent JL. Prevention and therapy of multiple organ failure. World J Surg. 1996;20:465-470.
2. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
3. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg. 1999;178:449-453.
4. Hassoun HT, Kone BC, Mercer DW, et al. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1-10.
5. Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and multiple organ dysfunction syndrome. Am J Gastroenterol. 1996;91:1697-1710.
6. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411-417.
7. Deitch EA, Xu DZ, Franko L, et al. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1994;1:141-145.
8. Sambol JT, Xu DZ, Adams CA, et al. Mesenteric lymph duct ligation provides long term protection against hemorrhagic shockinduced lung injury. Shock. 2000;14:416-419.
9. Gonzalez RJ, Moore EE, Ciesla DJ, et al. Mesenteric lymph is responsible for post-hemorrhagic shock systemic neutrophil priming. J Trauma. 2001;51:1069-1072.
10. Bathe OH, Chow AW, Phang PT. Splanchnic origin of cytokines in a porcine model of mesenteric ischemia-reperfusion. Surgery. 1998;123:79-88.
11. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous mediator of leukocyte adhesion. Proc Natl Acad Sci. 1991;88:4651-4655.
12. Hierholzer C, Kalff JC, Billiar TR, et al. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Gastrointest Physiol. 2002;286:G225-G233.
13. Hierholzer C, Harbrecht B, Menezes JM, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 1998;187:917-928.
14. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 1996;6:79-88.
15. Naito Y, Takagi T, Ichikawa H, et al. A novel potent inhibitor of inducible nitric oxide inhibitor ONO-1714 reduces intestinal ischemia-reperfusion jury in rats. Nitric Oxide. 2004;10:170-177.
16. Suzuki Y, Deitch EA, Mishima S, et al. Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 2000;28:3692-3696.
17. Alam HB, Stanton K, Koustova E, et al. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation. 2004;60:91-99.
18. Alam HB, Sun L, Ruff P, et al. E- and P-selectin expression depends on the resuscitation fluid used in hemorrhaged rats. J Surg Res. 2000;94:145-152.
19. Savage SA, Fitzpatrick CM, Kashyap V, et al. Endothelial dysfunction after lactated ringer's solution resuscitation for hemorrhagic shock. J Trauma. 2005;59:284-290.
20. Ayuste EC, Chen H, Koustova E, et al. Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications in conventional ringer's solution. J Trauma. 2006;60:52-63.
21. Koustova E, Stanton K, Gushchin V, et al. Effects of lactated ringer's solutions on human leukocytes. J Trauma. 2002;52:872-878.
22. Coimbra R, Loomis WH, Melbostad H, et al. Role of hypertonic saline and pentoxifylline on neutrophil activation and tumor necrosis factor-α synthesis: a novel resuscitation strategy. J Trauma. 2005;59:257-265.
23. Deree J, Martins JO, Leedom A, et al. Hypertronic saline and pentoxifylline reduces hemorrhagic shock resuscitation-induced pulmonary inflammation through attenuation of neutrophil degranulation and pro-inflammatory mediator synthesis. J Trauma. 2007;62:104-111.
24. Coimbra R, Porcides R, Loomis WH, et al. HSPTX protects against hemorrhagic shock resuscitation-induced tissue injury: an attractive alternative to ringer's lactate. J Trauma. 2006;60:41-51.
25. Kirkeboen KA, Strand OA. The role of nitric oxide in sepsis: an overview. Acta Anaesthesiol Scand. 1999;43:275-288.
26. McDonald PP, Bald A, Cassatella MA. Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood. 1997;89:3421-3433.
27. Renard P, Percherancier Y, Kroll M, et al. Inducible NF-κB activation is permitted by simultaneous degradation of nuclear IκBα. J Biol Chem. 2000;275:15193-15199.
28. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 1991; 10:3805-3817.
29. Song M, Kellum JA. Interleukin-6. Crit Care Med. 2005;33:S463-S465.
30. Dayal SD, Hasko G, Lu Q, et al. Trauma/hemorrhagic shock mesenteric lymph upregulates adhesion molecule expression and IL-6 production in human umbilical vein cells. Shock. 2002;17:491-495.
31. Remick DG. Interleukin-8. Crit Care Med. 2005;33:S466-S467.
32. Bauer M, Bauer I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal. 2002;4:749-758.
33. Ryter SW, Otterbein LE, Morse D, et al. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem. 2002;234-235:249-263.
34. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990;125:403-404.
35. Meakins JL, Marshall JC. The gastrointestinal tract: the "motor" of multiple organ failure. Arch Surg. 1986;121:196-208.
36. Johnston TD, Fischer R, Chen Y, et al. Lung injury from gut ischemia: insensitivity to portal blood blow diversion. J Trauma. 1993;35:508-511.
37. Caruso JM, Feketeova E, Dayal S, et al. Factors in intestinal lymph after shock increase neutrophil adhesion molecule expression and pulmonary leukosequestration. J Trauma. 2003;55:727-733.
38. Senthil M, Brown M, Xu D, et al. Gut-lymph hypothesis of systemic inflammatory response syndrome/multiple-organ dysfunction syndrome: validating studies in a porcine model. J Trauma. 2006;60:958-967.
39. Sarin EL, Moore EE, Moore JB, et al. Systemic neutrophil priming by lipid mediators in post-shock mesenteric lymph exists across species. J Trauma. 2004;57:950-954.
40. Shi HP, Deitch EA, Xu DZ, et al. Hypertonic saline improves intestinal mucosa barrier function and lung injury after traumahemorrhagic shock. Shock. 2002;17:496-501.
41. Barroso-Aranda J, Schmid-Schonbein GW. Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology. 1990;27:401-418.
42. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock. 1998;9:164-170.
43. Yada-Langui MM, Coimbra R, Lancellotti C, et al. Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after shock. Shock. 2000;14:594-598.
44. Coimbra R, Melbostad H, Hoyt DB. Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline. J Trauma. 2004;56:442-449.
45. Pascual JL, Ferri LE, Seely AJ, et al. Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduced in vivo vascular leakage. Ann Surg. 2002;236:634-642.
46. Coe DA, Freischlag JA, Johnson D, et al. Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res. 1997;67:21-25.
47. D'hellencourt CL, Diaw L, Cornillet P, et al. Differential regulation of TNF-α, IL-1β, IL-6, IL-8, TNF-β, and IL-10 by Pentoxifylline. Int J Immunopharmacol. 1996;18:739-748.
48. Matuschak GM, Lamprech KE, Lechner AJ. Pentoxifylline inhibits tumor necrosis factor production in septic shock. J Interferon Res. 1994;14:392-295.
49. Committee on Trauma. Advanced trauma life support for doctors, instructor manual. 6th ed. Chicago, Ill: American College of Surgeons; 1997.
50. Tamion F, Richard V, Sauger F, et al. Gastric mucosal acidosis and cytokine release in patients with septic shock. Crit Care Med. 2003;31:2137-2143.
51. Cruz RJ, Yada-Langui MM, Poli de Figueiredo LF, et al. The synergistic effects of pentoxifylline on systemic and regional perfusion after hemorrhage and hypertonic resuscitation. Anesth Analg. 2006;102:1518-1524.
52. Homma H, Deitch EA, Feketeova E, et al. Small volume resuscitation with hypertonic saline is more effective in ameliorating trauma-hemorrhagic shock-induced lung injury, neutrophil activation, and red blood cell dysfunction than pancreatic protease inhibition. J Trauma. 2005;59:266-272.
53. Scalia SV, Taheri PA, Force S, et al. Mesenteric microcirculatory changes in nonlethal hemorrhagic shock: the role of resuscitation with balanced electrolyte or hypertonic saline/dextran. J Trauma. 1992;33:321-325.
54. Yada-Langui MM, Anjos-Valotta EA, Sannomiya P, et al. Resuscitation affects microcirculatory polymorph nuclear leukocyte behavior after hemorrhagic shock: role of hypertonic saline and pentoxifylline. Exp Boil Med. 2004;684-693.
55. Szabo C, Billiar TR. Novel roles of nitric oxide in hemorrhagic shock. Shock. 1999;12:1-9.
56. Orlic T, Loomis WH, Shreve A, et al. Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and -independent mechanisms. Am J Physiol Cell Physiol. 2002;282:C1621-C1269.
57. Chong TJ, Victorino GP. Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal transduction and regulation of postcapillary fluid leak. J Trauma. 2005;59:302-307.
58. phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell Signal. 1996;8:291-296.
59. Lathi A, Lahde M, Kankaanranta H, et al. Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. J Pharmacol Exp Ther. 2000;294:1188-1194.